Revenue growth for the full year 2022 was approximately 4% year over year. Organic revenue growth for the full year 2022 was approximately 7% year over year. The company expects to deliver full year 2022 adjusted EBIT above outlook and free cash flow towards the low end of the range provided at GE HealthCare’s December 8 Investor Day on both a GE and GEHC basis.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on GEHC: